News

iSpecimen to Report First Quarter 2023 Results on May 4, 2023

LEXINGTON, Mass., April 20, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that…

2 years ago

Inovalon Expands Revenue Cycle Data Analytics Software to Support All EDI Clearinghouses for Healthcare Providers

SaaS Solution Delivers up to 93% First-Pass Yield and Prevents Revenue Leakage While Improving Cash Flow by up to 15%BOWIE,…

2 years ago

PersonalRX Acquires New York-Based Pharmacy

Expands high-touch, one-on-one approach to all patients in New York including MedicaidEAST RUTHERFORD, N.J., April 19, 2023 (GLOBE NEWSWIRE) --…

2 years ago

Relievant Medsystems Raises $50 Million to Advance the Treatment for Chronic Vertebrogenic Low Back Pain

MINNEAPOLIS, April 19, 2023 (GLOBE NEWSWIRE) --  Relievant Medsystems, a company dedicated to transforming the diagnosis and treatment of vertebrogenic…

2 years ago

Lumos Pharma to Report First Quarter 2023 Financial Results and Host Conference Call on May 3, 2023

AUSTIN, Texas, April 19, 2023 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a biopharmaceutical company advancing an oral therapeutic candidate…

2 years ago

Parexel Appoints Scott Smith, M.D., Ph.D. as New Head of Hematology

Addition of new therapeutic expert reflects company’s commitment to drug development in hematologyDURHAM, N.C., April 19, 2023 (GLOBE NEWSWIRE) --…

2 years ago

Ambrx Presents New Preclinical Data on ARX517 and ARX305 at the 2023 AACR Annual Meeting

SAN DIEGO, April 19, 2023 (GLOBE NEWSWIRE) -- Ambrx Biopharma Inc., or Ambrx (NASDAQ: AMAM), announced new preclinical data at…

2 years ago

Onconova Therapeutics Announces the Presentation of New Preclinical Data on Narazaciclib at the AACR Annual Meeting

Data further characterize narazaciclib’s mechanism of action and show its anti-cancer activity comparing favorably to that of FDA-approved CDK 4/6…

2 years ago

Bioxytran Tests Acellular Oxygen Carrier BXT-25 in Pre-Clinical Trials

BOSTON, MASSACHUSETTS, April 19, 2023 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (BIXT), (the “Company”), a clinical stage biotechnology company developing oral…

2 years ago